PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 214 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $2,951,000 | -17.9% | 55,699 | +19.0% | 0.62% | -12.4% |
Q4 2015 | $3,595,000 | -23.9% | 46,818 | -59.3% | 0.71% | -22.7% |
Q3 2015 | $4,727,000 | -36.4% | 115,018 | +9.5% | 0.92% | -13.3% |
Q2 2015 | $7,427,000 | +19.4% | 105,018 | +50.0% | 1.06% | +22.7% |
Q1 2015 | $6,221,000 | -61.0% | 70,018 | -61.1% | 0.86% | -60.5% |
Q4 2014 | $15,959,000 | – | 180,000 | – | 2.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |